SECPFMAPFMCreatine Supplementation for Fibromyalgia Symptoms
Creatine
+ Dextrose
Fibromyalgia+7
+ Muscular Diseases
+ Musculoskeletal Diseases
Other Study
Summary
Study start date: February 12, 2025
Actual date on which the first participant was enrolled.This study is investigating whether creatine, a compound often used by athletes to improve performance, can help reduce pain and fatigue in people with Fibromyalgia. Fibromyalgia is a condition characterized by widespread pain and tiredness that affects many people and can be quite debilitating. The aim is to see if taking creatine can provide relief more quickly than seen in previous studies, potentially offering a new way to manage symptoms for those affected by this condition. Participants in the study will be given creatine to see if it helps alleviate their symptoms. Researchers will carefully monitor how the participants' pain and fatigue levels change over time. They will also examine any changes in muscle structure to better understand creatine's effects. By measuring these outcomes, the study hopes to provide valuable information on whether creatine can be an effective treatment for reducing Fibromyalgia symptoms, which could lead to more options for those seeking relief.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.80 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location